By integrating microglial transcriptomics with CSF proteomics, this study reveals protein markers that distinguish early and late Alzheimer’s disease and that have the potential to improve disease tracking and prediction.
- Elena-Raluca Blujdea
- Pieter van Bokhoven
- Lisa Vermunt